{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:25:53Z","timestamp":1782285953057,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,3]]},"DOI":"10.7759\/cureus.28719","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T09:07:33Z","timestamp":1662196053000},"source":"Crossref","is-referenced-by-count":3,"title":["Immunoglobulin A Nephropathy in a SARS-CoV-2-Positive Patient With Coexistent Metabolic Syndrome"],"prefix":"10.7759","author":[{"given":"Pranjal","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iadarilang","family":"Tiewsoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio JV","year":"2002","unstructured":"Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002, 347:738-48. 10.1056\/NEJMra020109","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic RZ","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017, 12:2032-45. 10.2215\/CJN.11491116","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-18-4","article-title":"Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus","volume":"18","author":"Zhuo L","year":"2013","unstructured":"Zhuo L, Zou G, Li W, Lu J, Ren W. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res. 2013, 18:10.1186\/2047-783X-18-4","journal-title":"Eur J Med Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000495636","article-title":"Potential blood pressure goals in IgA nephropathy: prevalence, awareness, and treatment rates in chronic kidney disease among patients with hypertension in China (PATRIOTIC) study","volume":"43","author":"Zheng Y","year":"2018","unstructured":"Zheng Y, Wang Y, Liu S, et al.. Potential blood pressure goals in IgA nephropathy: prevalence, awareness, and treatment rates in chronic kidney disease among patients with hypertension in China (PATRIOTIC) study. Kidney Blood Press Res. 2018, 43:1786-95. 10.1159\/000495636","journal-title":"Kidney Blood Press Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/ijnrd.s303080","article-title":"Viral nephropathies, adding SARS-CoV-2 to the list","volume":"14","author":"Pramod S","year":"2021","unstructured":"Pramod S, Kheetan M, Ogu I, Alsanani A, Khitan Z. Viral nephropathies, adding SARS-CoV-2 to the list. Int J Nephrol Renovasc Dis. 2021, 14:157-64. 10.2147\/ijnrd.s303080","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-00356-5","article-title":"COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup","volume":"16","author":"Nadim MK","year":"2020","unstructured":"Nadim MK, Forni LG, Mehta RL, et al.. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020, 16:747-64. 10.1038\/s41581-020-00356-5","journal-title":"Nat Rev Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02163-3","article-title":"Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report","volume":"21","author":"Huang Y","year":"2020","unstructured":"Huang Y, Li XJ, Li YQ, et al.. Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report. BMC Nephrol. 2020, 21:10.1186\/s12882-020-02163-3","journal-title":"BMC Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.6.1183","article-title":"Prospective study on renal outcome of IgA nephropathy superimposed on diabetic glomerulosclerosis in type 2 diabetic patients","volume":"16","author":"Mak SK","year":"2001","unstructured":"Mak SK, Wong PN, Lo KY, Tong GM, Wong AK. Prospective study on renal outcome of IgA nephropathy superimposed on diabetic glomerulosclerosis in type 2 diabetic patients. Nephrol Dial Transplant. 2001, 16:1183-8. 10.1093\/ndt\/16.6.1183","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.12.2588","article-title":"Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus","volume":"12","author":"Mak SK","year":"1997","unstructured":"Mak SK, Gwi E, Chan KW, Wong PN, Lo KY, Lee KF, Wong AK. Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant. 1997, 12:2588-91. 10.1093\/ndt\/12.12.2588","journal-title":"Nephrol Dial Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80698-6","article-title":"The occurrence of IgA-nephropathy in patients with diabetes mellitus May not be coincidental: a report of five cases","volume":"20","author":"Gans RO","year":"1992","unstructured":"Gans RO, Ueda Y, Ito S, Kohli R, Min I, Shafi M, Brentjens JR. The occurrence of IgA-nephropathy in patients with diabetes mellitus May not be coincidental: a report of five cases. Am J Kidney Dis. 1992, 20:255-60. 10.1016\/S0272-6386(12)80698-6","journal-title":"Am J Kidney Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000045050","article-title":"IgA nephropathy complicating diabetic glomerulosclerosis","volume":"79","author":"Orfila C","year":"1998","unstructured":"Orfila C, Lepert JC, Modesto A, Pipy B, Suc JM. IgA nephropathy complicating diabetic glomerulosclerosis. Nephron. 1998, 79:279-87. 10.1159\/000045050","journal-title":"Nephron"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang PL","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009, 2:231-7. 10.1242\/dmm.001180","journal-title":"Dis Model Mech"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5551\/jat.12.295","article-title":"The metabolic syndrome: a global public health problem and a new definition","volume":"12","author":"Zimmet P","year":"2005","unstructured":"Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005, 12:295-300. 10.5551\/jat.12.295","journal-title":"J Atheroscler Thromb"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh920","article-title":"Renal protection in IgA nephropathy requires strict blood pressure control","volume":"20","author":"Nagy J","year":"2005","unstructured":"Nagy J, Kov\u00e1cs T, Wittmann I. Renal protection in IgA nephropathy requires strict blood pressure control. Nephrol Dial Transplant. 2005, 20:1533-9. 10.1093\/ndt\/gfh920","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang K","year":"2020","unstructured":"Wang K, Chen W, Zhang Z, et al.. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020, 5:10.1038\/s41392-020-00426-x","journal-title":"Signal Transduct Target Ther"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.34172\/jnp.2020.21","article-title":"COVID-19 nephropathy; an emerging condition encountered by novel coronavirus infection","volume":"9","author":"Mubarak M","year":"2020","unstructured":"Mubarak M, Nasri H. COVID-19 nephropathy; an emerging condition encountered by novel coronavirus infection. J Nephropathol. 2020, 9:1-2.","journal-title":"J Nephropathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs131","article-title":"Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy","volume":"6","author":"Kov\u00e1cs T","year":"2013","unstructured":"Kov\u00e1cs T, Vas T, Kovesdy CP, K\u00e9s\u00f5i I, S\u00e1gi B, Wittmann I, Nagy J. Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy. Clin Kidney J. 2013, 6:395-401. 10.1093\/ckj\/sfs131","journal-title":"Clin Kidney J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac208","article-title":"The role of dendrin in IgA nephropathy","author":"Levin A","year":"2022","unstructured":"Levin A, Schwarz A, Hulkko J, et al.. The role of dendrin in IgA nephropathy. Nephrol Dial Transplant. 2022, 10.1093\/ndt\/gfac208","journal-title":"Nephrol Dial Transplant"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2021.08.012","article-title":"The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: a systematic review","volume":"17","author":"Farooq H","year":"2022","unstructured":"Farooq H, Ur Rehman MA, Asmar A, Asif S, Mushtaq A, Qureshi MA. The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: a systematic review. J Taibah Univ Med Sci. 2022, 17:1-13. 10.1016\/j.jtumed.2021.08.012","journal-title":"J Taibah Univ Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2176","article-title":"COVID-19 and kidney injury: pathophysiology and molecular mechanisms","volume":"31","author":"Ahmadian E","year":"2021","unstructured":"Ahmadian E, Khatibi SM, Soofiyani SR, Abediazar S, Shoja MM, Ardalan M, Vahed SZ. COVID-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021, 31:10.1002\/rmv.2176","journal-title":"Rev Med Virol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/108725-immunoglobulin-a-nephropathy-in-a-sars-cov-2-positive-patient-with-coexistent-metabolic-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:58Z","timestamp":1707507658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/108725-immunoglobulin-a-nephropathy-in-a-sars-cov-2-positive-patient-with-coexistent-metabolic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.28719","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,3]]}}}